APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gene Service Market Analysis and Forecast 2026-2032

30 January 2026192 pages

Choose your research edition.

Industry ResearchGene Service Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Service Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Gene Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Service Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Service Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Gene Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Gene Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gene Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gene Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gene Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Gene Service include LipExoGen Biotech, Synbio Technologies, Genscript Biotech Corporation, Creative Biogene, GENEWIZ, Bio-Techne, Charles River Laboratories, Geneservice and Boston Medical Center, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Gene Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gene Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Gene Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gene Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gene Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gene Service revenue, projected growth trends, production technology, application and end-user industry.

Gene Service Segment by Company

LipExoGen Biotech

Synbio Technologies

Genscript Biotech Corporation

Creative Biogene

GENEWIZ

Bio-Techne

Charles River Laboratories

Geneservice

Boston Medical Center

DefiGEN

NHS England

Integrated DNA Technologies

Blossom

Aldevron

Biocytogen

Gene Service Segment by Type

Gene Synthesis

Gene Cloning

Gene Mutagenesis

Gene Regulation

Gene Service Segment by Application

Medical

Biological

Gene Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Gene Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Gene Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gene Synthesis Major Player Table 3. Gene Cloning Major Player Table 4. Gene Mutagenesis Major Player Table 5. Gene Regulation Major Player Table 6. Global Gene Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Medical Major Player Table 8. Biological Major Player Table 9. Gene Service Industry Trends Table 10. Gene Service Industry Drivers Table 11. Gene Service Industry Opportunities and Challenges Table 12. Gene Service Industry Restraints Table 13. Global Gene Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Gene Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Gene Service Market Share by Region (2021-2026) Table 16. Global Gene Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Gene Service Market Share by Region (2027-2032) Table 18. Global Gene Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Gene Service Revenue Market Share by Players (2021-2026) Table 20. Global Gene Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Gene Service Key Players Headquarters & Area Served Table 22. Global Gene Service Players, Product Type & Application Table 23. Global Gene Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Gene Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Gene Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Gene Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Gene Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Gene Service Revenue Market Share by Type (2021-2026) Table 30. Global Gene Service Revenue Market Share by Type (2027-2032) Table 31. Global Gene Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Gene Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Gene Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Gene Service Revenue Market Share by Application (2021-2026) Table 35. Global Gene Service Revenue Market Share by Application (2027-2032) Table 36. LipExoGen Biotech Company Information Table 37. LipExoGen Biotech Business Overview Table 38. LipExoGen Biotech Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. LipExoGen Biotech Gene Service Product Portfolio Table 40. LipExoGen Biotech Recent Development Table 41. Synbio Technologies Company Information Table 42. Synbio Technologies Business Overview Table 43. Synbio Technologies Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Synbio Technologies Gene Service Product Portfolio Table 45. Synbio Technologies Recent Development Table 46. Genscript Biotech Corporation Company Information Table 47. Genscript Biotech Corporation Business Overview Table 48. Genscript Biotech Corporation Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Genscript Biotech Corporation Gene Service Product Portfolio Table 50. Genscript Biotech Corporation Recent Development Table 51. Creative Biogene Company Information Table 52. Creative Biogene Business Overview Table 53. Creative Biogene Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Creative Biogene Gene Service Product Portfolio Table 55. Creative Biogene Recent Development Table 56. GENEWIZ Company Information Table 57. GENEWIZ Business Overview Table 58. GENEWIZ Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. GENEWIZ Gene Service Product Portfolio Table 60. GENEWIZ Recent Development Table 61. Bio-Techne Company Information Table 62. Bio-Techne Business Overview Table 63. Bio-Techne Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Bio-Techne Gene Service Product Portfolio Table 65. Bio-Techne Recent Development Table 66. Charles River Laboratories Company Information Table 67. Charles River Laboratories Business Overview Table 68. Charles River Laboratories Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Charles River Laboratories Gene Service Product Portfolio Table 70. Charles River Laboratories Recent Development Table 71. Geneservice Company Information Table 72. Geneservice Business Overview Table 73. Geneservice Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Geneservice Gene Service Product Portfolio Table 75. Geneservice Recent Development Table 76. Boston Medical Center Company Information Table 77. Boston Medical Center Business Overview Table 78. Boston Medical Center Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Boston Medical Center Gene Service Product Portfolio Table 80. Boston Medical Center Recent Development Table 81. DefiGEN Company Information Table 82. DefiGEN Business Overview Table 83. DefiGEN Gene Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. DefiGEN Gene Service Product Portfolio Table 85. DefiGEN Recent Development Table 86. NHS England Company Information Table 87. NHS England Business Overview Table 88. NHS England Gene Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. NHS England Gene Service Product Portfolio Table 90. NHS England Recent Development Table 91. Integrated DNA Technologies Company Information Table 92. Integrated DNA Technologies Business Overview Table 93. Integrated DNA Technologies Gene Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Integrated DNA Technologies Gene Service Product Portfolio Table 95. Integrated DNA Technologies Recent Development Table 96. Blossom Company Information Table 97. Blossom Business Overview Table 98. Blossom Gene Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Blossom Gene Service Product Portfolio Table 100. Blossom Recent Development Table 101. Aldevron Company Information Table 102. Aldevron Business Overview Table 103. Aldevron Gene Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Aldevron Gene Service Product Portfolio Table 105. Aldevron Recent Development Table 106. Biocytogen Company Information Table 107. Biocytogen Business Overview Table 108. Biocytogen Gene Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Biocytogen Gene Service Product Portfolio Table 110. Biocytogen Recent Development Table 111. North America Gene Service Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Gene Service Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Gene Service Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Gene Service Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Gene Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Gene Service Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Gene Service Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Gene Service Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Gene Service Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Gene Service Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Gene Service Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Gene Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Gene Service Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Gene Service Revenue by Country (US$ Million) & (2027-2032) Table 125. China Gene Service Revenue by Type (2021-2026) & (US$ Million) Table 126. China Gene Service Revenue by Type (2027-2032) & (US$ Million) Table 127. China Gene Service Revenue by Application (2021-2026) & (US$ Million) Table 128. China Gene Service Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Gene Service Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Gene Service Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Gene Service Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Gene Service Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Gene Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Gene Service Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Gene Service Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Gene Service Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Gene Service Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Gene Service Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Gene Service Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Gene Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Gene Service Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Gene Service Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Gene Service Image Figure 2. Global Gene Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gene Synthesis Image Figure 5. Gene Cloning Image Figure 6. Gene Mutagenesis Image Figure 7. Gene Regulation Image Figure 8. Global Gene Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Gene Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Medical Image Figure 11. Biological Image Figure 12. Global Gene Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Gene Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gene Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Gene Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Gene Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Gene Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Gene Service Revenue Market Share by Type (2021-2032) Figure 20. Global Gene Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Gene Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Gene Service Revenue Market Share by Application (2021-2032) Figure 23. North America Gene Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Gene Service Revenue Share by Type (2021-2032) Figure 25. North America Gene Service Revenue Share by Application (2021-2032) Figure 26. North America Gene Service Revenue Share by Country (2021-2032) Figure 27. United States Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Gene Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Gene Service Revenue Share by Type (2021-2032) Figure 32. Europe Gene Service Revenue Share by Application (2021-2032) Figure 33. Europe Gene Service Revenue Share by Country (2021-2032) Figure 34. Germany Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Gene Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Gene Service Revenue Share by Type (2021-2032) Figure 44. China Gene Service Revenue Share by Application (2021-2032) Figure 45. Asia Gene Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Gene Service Revenue Share by Type (2021-2032) Figure 47. Asia Gene Service Revenue Share by Application (2021-2032) Figure 48. Asia Gene Service Revenue Share by Region (2021-2032) Figure 49. Japan Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Gene Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Gene Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Gene Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Gene Service Revenue Share by Country (2021-2032) Figure 59. Brazil Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Gene Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Synthesis
  • Gene Cloning
  • Gene Mutagenesis
  • Gene Regulation
Applications
  • Medical
  • Biological
Companies covered
  • LipExoGen Biotech
  • Synbio Technologies
  • Genscript Biotech Corporation
  • Creative Biogene
  • GENEWIZ
  • Bio-Techne
  • Charles River Laboratories
  • Geneservice
  • Boston Medical Center
  • DefiGEN
  • NHS England
  • Integrated DNA Technologies
  • Blossom
  • Aldevron
  • Biocytogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gene Service Market by Type
  3. 1.2.1 Global Gene Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gene Synthesis
  5. 1.2.3 Gene Cloning
  6. 1.2.4 Gene Mutagenesis
  7. 1.2.5 Gene Regulation
  8. 1.3 Gene Service Market by Application
  9. 1.3.1 Global Gene Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Medical
  11. 1.3.3 Biological
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Gene Service Market Dynamics
  1. 2.1 Gene Service Industry Trends
  2. 2.2 Gene Service Industry Drivers
  3. 2.3 Gene Service Industry Opportunities and Challenges
  4. 2.4 Gene Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Gene Service Market Perspective (2021-2032)
  2. 3.2 Global Gene Service Growth Trends by Region
  3. 3.2.1 Global Gene Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gene Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Gene Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Gene Service Revenue by Players
  2. 4.1.1 Global Gene Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Gene Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Gene Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gene Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Gene Service Key Players Headquarters & Area Served
  7. 4.4 Global Gene Service Players, Product Type & Application
  8. 4.5 Global Gene Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Gene Service Market CR5 and HHI
  11. 4.6.3 2025 Gene Service Tier 1, Tier 2, and Tier 3
5 Gene Service Market Size by Type
  1. 5.1 Global Gene Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Service Revenue by Type (2021-2032)
  3. 5.3 Global Gene Service Revenue Market Share by Type (2021-2032)
6 Gene Service Market Size by Application
  1. 6.1 Global Gene Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Gene Service Revenue by Application (2021-2032)
  3. 6.3 Global Gene Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 LipExoGen Biotech
  2. 7.1.1 LipExoGen Biotech Company Information
  3. 7.1.2 LipExoGen Biotech Business Overview
  4. 7.1.3 LipExoGen Biotech Gene Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 LipExoGen Biotech Gene Service Product Portfolio
  6. 7.1.5 LipExoGen Biotech Recent Developments
  7. 7.2 Synbio Technologies
  8. 7.2.1 Synbio Technologies Company Information
  9. 7.2.2 Synbio Technologies Business Overview
  10. 7.2.3 Synbio Technologies Gene Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Synbio Technologies Gene Service Product Portfolio
  12. 7.2.5 Synbio Technologies Recent Developments
  13. 7.3 Genscript Biotech Corporation
  14. 7.3.1 Genscript Biotech Corporation Company Information
  15. 7.3.2 Genscript Biotech Corporation Business Overview
  16. 7.3.3 Genscript Biotech Corporation Gene Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Genscript Biotech Corporation Gene Service Product Portfolio
  18. 7.3.5 Genscript Biotech Corporation Recent Developments
  19. 7.4 Creative Biogene
  20. 7.4.1 Creative Biogene Company Information
  21. 7.4.2 Creative Biogene Business Overview
  22. 7.4.3 Creative Biogene Gene Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Creative Biogene Gene Service Product Portfolio
  24. 7.4.5 Creative Biogene Recent Developments
  25. 7.5 GENEWIZ
  26. 7.5.1 GENEWIZ Company Information
  27. 7.5.2 GENEWIZ Business Overview
  28. 7.5.3 GENEWIZ Gene Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 GENEWIZ Gene Service Product Portfolio
  30. 7.5.5 GENEWIZ Recent Developments
  31. 7.6 Bio-Techne
  32. 7.6.1 Bio-Techne Company Information
  33. 7.6.2 Bio-Techne Business Overview
  34. 7.6.3 Bio-Techne Gene Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bio-Techne Gene Service Product Portfolio
  36. 7.6.5 Bio-Techne Recent Developments
  37. 7.7 Charles River Laboratories
  38. 7.7.1 Charles River Laboratories Company Information
  39. 7.7.2 Charles River Laboratories Business Overview
  40. 7.7.3 Charles River Laboratories Gene Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Charles River Laboratories Gene Service Product Portfolio
  42. 7.7.5 Charles River Laboratories Recent Developments
  43. 7.8 Geneservice
  44. 7.8.1 Geneservice Company Information
  45. 7.8.2 Geneservice Business Overview
  46. 7.8.3 Geneservice Gene Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Geneservice Gene Service Product Portfolio
  48. 7.8.5 Geneservice Recent Developments
  49. 7.9 Boston Medical Center
  50. 7.9.1 Boston Medical Center Company Information
  51. 7.9.2 Boston Medical Center Business Overview
  52. 7.9.3 Boston Medical Center Gene Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Boston Medical Center Gene Service Product Portfolio
  54. 7.9.5 Boston Medical Center Recent Developments
  55. 7.10 DefiGEN
  56. 7.10.1 DefiGEN Company Information
  57. 7.10.2 DefiGEN Business Overview
  58. 7.10.3 DefiGEN Gene Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 DefiGEN Gene Service Product Portfolio
  60. 7.10.5 DefiGEN Recent Developments
  61. 7.11 NHS England
  62. 7.11.1 NHS England Company Information
  63. 7.11.2 NHS England Business Overview
  64. 7.11.3 NHS England Gene Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 NHS England Gene Service Product Portfolio
  66. 7.11.5 NHS England Recent Developments
  67. 7.12 Integrated DNA Technologies
  68. 7.12.1 Integrated DNA Technologies Company Information
  69. 7.12.2 Integrated DNA Technologies Business Overview
  70. 7.12.3 Integrated DNA Technologies Gene Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Integrated DNA Technologies Gene Service Product Portfolio
  72. 7.12.5 Integrated DNA Technologies Recent Developments
  73. 7.13 Blossom
  74. 7.13.1 Blossom Company Information
  75. 7.13.2 Blossom Business Overview
  76. 7.13.3 Blossom Gene Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Blossom Gene Service Product Portfolio
  78. 7.13.5 Blossom Recent Developments
  79. 7.14 Aldevron
  80. 7.14.1 Aldevron Company Information
  81. 7.14.2 Aldevron Business Overview
  82. 7.14.3 Aldevron Gene Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Aldevron Gene Service Product Portfolio
  84. 7.14.5 Aldevron Recent Developments
  85. 7.15 Biocytogen
  86. 7.15.1 Biocytogen Company Information
  87. 7.15.2 Biocytogen Business Overview
  88. 7.15.3 Biocytogen Gene Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Biocytogen Gene Service Product Portfolio
  90. 7.15.5 Biocytogen Recent Developments
8 North America
  1. 8.1 North America Gene Service Revenue (2021-2032)
  2. 8.2 North America Gene Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Gene Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Gene Service Revenue by Type (2027-2032)
  5. 8.3 North America Gene Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Gene Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Gene Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Gene Service Revenue by Application (2027-2032)
  9. 8.5 North America Gene Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Gene Service Revenue by Country
  11. 8.6.1 North America Gene Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Gene Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Gene Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Gene Service Revenue (2021-2032)
  2. 9.2 Europe Gene Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Gene Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Gene Service Revenue by Type (2027-2032)
  5. 9.3 Europe Gene Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Gene Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Gene Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Gene Service Revenue by Application (2027-2032)
  9. 9.5 Europe Gene Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Gene Service Revenue by Country
  11. 9.6.1 Europe Gene Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Gene Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Gene Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Gene Service Revenue (2021-2032)
  2. 10.2 China Gene Service Revenue by Type (2021-2032)
  3. 10.2.1 China Gene Service Revenue by Type (2021-2026)
  4. 10.2.2 China Gene Service Revenue by Type (2027-2032)
  5. 10.3 China Gene Service Revenue Share by Type (2021-2032)
  6. 10.4 China Gene Service Revenue by Application (2021-2032)
  7. 10.4.1 China Gene Service Revenue by Application (2021-2026)
  8. 10.4.2 China Gene Service Revenue by Application (2027-2032)
  9. 10.5 China Gene Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gene Service Revenue (2021-2032)
  2. 11.2 Asia Gene Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Gene Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Gene Service Revenue by Type (2027-2032)
  5. 11.3 Asia Gene Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Gene Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Gene Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Gene Service Revenue by Application (2027-2032)
  9. 11.5 Asia Gene Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Gene Service Revenue by Country
  11. 11.6.1 Asia Gene Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Gene Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Gene Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gene Service Revenue (2021-2032)
  2. 12.2 SAMEA Gene Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Gene Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Gene Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Gene Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Gene Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Gene Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Gene Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Gene Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Gene Service Revenue by Country
  11. 12.6.1 SAMEA Gene Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Gene Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Gene Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst